264
Participants
Start Date
November 7, 2023
Primary Completion Date
June 18, 2025
Study Completion Date
July 2, 2025
SAR441566
Tablet
Placebo
Tablet
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320003, Buenos Aires
Investigational Site Number : 0320007, Buenos Aires
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320005, Berazategui
Investigational Site Number : 0320002, San Miguel de Tucumán
Investigational Site Number : 7100002, Cape Town
Investigational Site Number : 7100003, Cape Town
Investigational Site Number : 0320006, Mar del Plata
Investigational Site Number : 7100007, Stellenbosch
Investigational Site Number : 7240008, Chiclana de la Frontera
Investigational Site Number : 2760002, Berlin
Investigational Site Number : 7240001, A Coruña
Investigational Site Number : 7240002, Santiago de Compostela
Investigational Site Number : 7240006, Santiago de Compostela
Altoona Center for Clinical Research- Site Number : 8400002, Duncansville
Investigational Site Number : 2760001, Hamburg
Investigational Site Number : 7240007, Madrid
Arthritis and Osteoporosis Consultants of the Carolinas- Site Number : 8400012, Charlotte
Carolina Specialty Care- Site Number : 8400007, Statesville
Investigational Site Number : 7240003, Málaga
Low Country Rheumatology- Site Number : 8400018, Summerville
Investigational Site Number : 4840001, Chihuahua City
UF Health Deerwood Park- Site Number : 8400020, Jacksonville
Innovia Research Center, Inc- Site Number : 8400026, Miramar
Life Clinical Trials- Site Number : 8400028, Margate
Future Care Solution - Miami- Site Number : 8400019, Miami
Integral Rheumatology and Immunology Specialists- Site Number : 8400010, Plantation
Clinical Research of West Florida - Tampa - North Howard Avenue- Site Number : 8400017, Tampa
Investigational Site Number : 2760003, Ratingen
Investigational Site Number : 7240005, Seville
American Indian Clinical Trials Research Network - Rapid City- Site Number : 8400022, Rapid City
Investigational Site Number : 4800001, Vacoas
AARA Clinical Research - Lone Star Arthritis & Rheumatology Associates - Irving- Site Number : 8400031, Irving
Prolato Clinical Research Center- Site Number : 8400021, Houston
Perceptive Pharma Research- Site Number : 8400009, Richmond
Inspire Santa Fe Medical Group- Site Number : 8400029, Santa Fe
Amicis Research Center - Northridge - Nordhoff Street- Site Number : 8400023, Northridge
Inland Rheumatology & Osteoporosis Medical Group- Site Number : 8400004, Upland
Investigational Site Number : 4840003, Mérida
Investigational Site Number : 1560001, Shanghai
Investigational Site Number : 1560003, Hefei
Investigational Site Number : 3560006, Ahmedabad
Investigational Site Number : 3560005, Surat
Investigational Site Number : 3560011, Nashik
Investigational Site Number : 3560010, Hyderabad
Investigational Site Number : 3560002, Bengaluru
Investigational Site Number : 3560001, Chennai
Investigational Site Number : 1560004, Chengdu
Investigational Site Number : 3560007, Kolkata
Investigational Site Number : 1520001, La Serena
Investigational Site Number : 1520007, Viña del Mar
Investigational Site Number : 1520002, Talca
Investigational Site Number : 1520005, Valdivia
Investigational Site Number : 1520003, Osorno
Investigational Site Number : 1520004, Santiago
Investigational Site Number : 1520006, Santiago
Investigational Site Number : 1520008, Santiago
Investigational Site Number : 1520009, Santiago
Investigational Site Number : 0320002, San Miguel de Tucumán
Centro Mineiro de Pesquisa- Site Number : 0760003, Juiz de Fora
Centro de Estudos em Terapias Inovadoras- Site Number : 0760004, Curitiba
Hospital São Lucas Copacabana- Site Number : 0760007, Rio de Janeiro
CCBR / IBPClin - Instituto Brasil de Pesquisa Clínica- Site Number : 0760005, Rio de Janeiro
Centro Paulista de Investigaçăo Clínica - CEPIC- Site Number : 0760001, São Paulo
Investigational Site Number : 1240006, Calgary
Investigational Site Number : 1240001, Brampton
Investigational Site Number : 1240004, Windsor
Investigational Site Number : 1240002, Sherbrooke
Investigational Site Number : 2030006, Brno
Investigational Site Number : 2030002, Ostrava
Investigational Site Number : 2030008, Pardubice
Investigational Site Number : 2030001, Prague
Investigational Site Number : 2030003, Uherské Hradiště
Investigational Site Number : 2680001, Tbilisi
Investigational Site Number : 3000001, Athens
Investigational Site Number : 3000002, Heraklion
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 3920005, Nagoya
Investigational Site Number : 3920007, Kamogawa
Investigational Site Number : 3920006, Sapporo
Investigational Site Number : 3920009, Sapporo
Investigational Site Number : 3920004, Kawachi-Nagano
Investigational Site Number : 3920003, Toyonaka
Investigational Site Number : 3920002, Fuchū
Investigational Site Number : 3920008, Nagasaki
Investigational Site Number : 3920011, Tokorozawa
Investigational Site Number : 3920001, Toyota
Investigational Site Number : 4840002, Mexico City
Investigational Site Number : 6160004, Poznan
Investigational Site Number : 6160001, Lublin
Investigational Site Number : 6160002, Lublin
Investigational Site Number : 6160003, Bialystok
Investigational Site Number : 6160005, Bytom
Investigational Site Number : 6160006, Grodzisk Mazowiecki
Caribbean Medical Research Center- Site Number : 8400027, San Juan
Investigational Site Number : 7030003, Nové Mesto nad Váhom
Investigational Site Number : 7030001, Piešťany
Investigational Site Number : 7100001, Pretoria
Investigational Site Number : 7100005, Pretoria
Investigational Site Number : 7100004, Pretoria
Investigational Site Number : 7240004, Sabadell
Lead Sponsor
Sanofi
INDUSTRY